ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2021

The Reliability of Scoring Sonographic Entheseal Abnormalities – the Diagnostic Ultrasound Enthesitis Tool (DUET) Study

Lihi Eder1, Sibel Aydin2 and Gurjit Kaeley3, 1Women’s College Research Institute, University of Toronto, Toronto, ON, Canada, 2University of Ottawa Faculty of Medicine, Rheumatology, Ottawa, ON, CANADA; The Ottawa Hospital Research Institute, Ottawa, ON, CANADA, Ottawa, ON, Canada, 3University of Florida College of Medicine - Jacksonville, Jacksonville, FL

Meeting: ACR Convergence 2020

Keywords: Imaging, Measurement Instrument, Psoriatic arthritis, spondyloarthritis, Ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Session Title: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes III: Imaging in SpA (2018–2022)

Session Type: Abstract Session

Session Time: 5:00PM-5:50PM

Background/Purpose: DUET is a study supported by the Group for Assessment for Psoriasis and Psoriatic Arthritis (GRAPPA) that aims to develop a novel sonographic scoring system for enthesitis to assist with PsA diagnosis. The objectives of the present study are to define the elementary lesions of enthesitis for the DUET study and to assess the inter-rater reliability of the central readers in scoring these lesions.

Methods: The DUET study steering committee, that included three experienced sonographers, reached a consensus regarding the definitions and grading of the sonographic elementary lesions for enthesitis that will be used in the study. The following elementary lesions were considered: hypoechogenicity (yes/no), thickening (yes/no and quantitative), enthesophyte (graded 0-3), erosion (yes/no), calcification (graded 0-3), bursitis (graded 0-2) and Power Doppler (graded 0-3). An atlas with images depicting each elementary lesion was created (Figure 1). For the inter-rater reliability assessment the three readers were asked to score 18 sets of short video clips of ultrasound scans from patients with active PsA. Each set included B-mode and Doppler scans that followed the DUET scanning protocol and included 16 entheseal sites around the knee, ankle, elbow and shoulder. The readers were blinded to the clinical data. Inter-rater reliability was calculated using Kappa statistics (K) for categorical variables and intraclass correlation coefficient (ICC) for continuous variables.

Results: A total of 262 entheseal sites were scored. The prevalence of the elementary lesions (range by reader) were: hypoechogenicity (53.4-54.8%), thickening (26-43.2%), erosion (7.7-10.9%), enthesophyte (48.2-61.3%), calcification (3.4-11.5%), Doppler signal (27.1-42.2%) and bursitis (12-22.5%). The inter-rater agreement ranged from excellent to fair as follows (Table 1): Doppler (K=0.87), enthesophyte (K=0.75), erosion (K=0.73), bursitis (K=0.60), hypoechogenicity (K=0.47), thickening (K=0.47), calcification (K=0.22). Thickness measurement and the total score per entheseal site showed very good inter-rater agreement (ICC of 0.78 and 0.82, respectively). The agreement for hypoechogenicity and thickening varied by site being lowest for the plantar fascia, supraspinatus, quadriceps and lateral epicondyle.

Conclusion: Good agreement was found between expert sonographers for scoring the majority of the entheseal sonographic lesions for the DUET study.

Scoring of Sonographic Elementary Lesion – The DUET Study

Inter-Rater Agreement for Scoring of Entheseal Lesions (N=262 entheseal Sites, 18 patients)


Disclosure: L. Eder, AbbVie, 2, 5, 8, Eli Lilly, 2, 5, Pfizer Inc, 2, 5, UCB, 2, 5, 8, Celgene, 5, Novartis, 5; S. Aydin, None; G. Kaeley, Novartis Pharmaceuticals Corporation, 5.

To cite this abstract in AMA style:

Eder L, Aydin S, Kaeley G. The Reliability of Scoring Sonographic Entheseal Abnormalities – the Diagnostic Ultrasound Enthesitis Tool (DUET) Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-reliability-of-scoring-sonographic-entheseal-abnormalities-the-diagnostic-ultrasound-enthesitis-tool-duet-study/. Accessed July 4, 2022.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-reliability-of-scoring-sonographic-entheseal-abnormalities-the-diagnostic-ultrasound-enthesitis-tool-duet-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies